MALAT1 and lung carcinoma: Notably, high levels of MALAT1 confer resistance to pharmacological treatment, such as cisplatin in lung cancer [24], while, in ovarian cancer MALAT1 interferes with the Notch pathway, conferring chemo-resistance [23].